收藏切换
Research progress on metal β-lactamase inhibitors
收藏切换
Wan-cun WANG1, Ying-xun ZHOU1, Zhan-pan WU1, Guo-chun YANG1, Ling-yun CHEN1, 2, An-guo HOU1, 2, *, Wen-bin JIN1, 2, *
Acta Pharmaceutica Sinica | 2026, 61(3) : 727 - 737
Less
收藏切换
Acta Pharmaceutica Sinica | 2026, 61(3): 727-737
• Reviews •
Research progress on metal β-lactamase inhibitors
Full
Wan-cun WANG1, Ying-xun ZHOU1, Zhan-pan WU1, Guo-chun YANG1, Ling-yun CHEN1, 2, An-guo HOU1, 2, *, Wen-bin JIN1, 2, *
Affiliations
  • 1School of Traditional Chinese Medicine, Yunnan University of Chinese Medicine, Kunming 650500, China
  • 2Key Laboratory of External Drug Delivery System and Preparation Technology in Universities of Yunnan and Faculty of Chinese Materia Medica, Kunming 650500, China
Published: 2026-03-12 doi: 10.16438/j.0513-4870.2025-0615
Outline
收藏切换

Metallo-β-lactamases (MBLs) mediate carbapenem antibiotic resistance by hydrolyzing the β-lactam ring. However, existing inhibitors remain largely confined to laboratory research due to poor selectivity or insufficient potency, and no clinically approved MBL inhibitors are currently available. MBLs are categorized into three subclasses B1, B2, and B3. B1 and B3 subclasses possess a binuclear zinc catalytic center, whereas B2 harbors a single active zinc ion. Despite their structurally conserved active sites featuring a characteristic αβ/βα-fold architecture with catalytic zinc ions positioned between αβ units flanked by flexible loops. Meanwhile, candidates developed through enzymatic and thermodynamic studies, such as 2-quinazolinone QDP-1, boronic acid derivatives VNRX-5133/QPX7728, thiazolecarboxylic acid ANT2681, and selenium-containing compound SPI-1005, still face challenges in achieving broad-spectrum efficacy and clinical safety. This review systematically examines the interaction mechanisms between inhibitors and MBLs, focusing on three strategic approaches: Covalent binding strategies, zinc ion chelation, and allosteric inhibition. The synthesis aims to provide theoretical foundations and rational design strategies for developing potent, safe, and broad-spectrum metallo-β-lactamase inhibitors.

metal β-lactamase  /  inhibitor  /  mechanism  /  chemical structure  /  design strategy
王万存, 周应勋, 吴占攀, 杨国春, 陈凌云, 侯安国, 金文彬. 金属β-内酰胺酶抑制剂研究进展. 药学学报, 2026 , 61 (3) : 727 -737 . DOI: 10.16438/j.0513-4870.2025-0615
Wan-cun WANG, Ying-xun ZHOU, Zhan-pan WU, Guo-chun YANG, Ling-yun CHEN, An-guo HOU, Wen-bin JIN. Research progress on metal β-lactamase inhibitors[J]. Acta Pharmaceutica Sinica, 2026 , 61 (3) : 727 -737 . DOI: 10.16438/j.0513-4870.2025-0615
Year 2026 volume 61 Issue 3
230
107
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2025-0615
  • Receive Date:2025-05-29
  • Online Date:2026-09-21
  • Published:2026-03-12
Article Data
Affiliations
History
  • Received:2025-05-29
  • Revised:2025-08-09
Affiliations
    1School of Traditional Chinese Medicine, Yunnan University of Chinese Medicine, Kunming 650500, China
    2Key Laboratory of External Drug Delivery System and Preparation Technology in Universities of Yunnan and Faculty of Chinese Materia Medica, Kunming 650500, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2025-0615
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT